Infectious Disease Pharmacology
1. Antimicrobial Stewardship & General Nursing Principles
Antimicrobial stewardship ensures optimal selection, dosage, and duration of anti-infective therapy to maximize clinical cure while minimizing resistance and adverse drug events.
Core Antimicrobial Nursing Rules
- Culture and Sensitivity (C&S): Always obtain biological cultures (blood, urine, sputum, wound) prior to initiating the first dose of antibiotic therapy. Broad-spectrum antibiotics may be started empirically while awaiting C&S results, followed by de-escalation to a targeted narrow-spectrum antibiotic once sensitivities return.
- Superinfections: Broad-spectrum antibiotics eradicate normal resident flora in the gut, vagina, and respiratory tract, predisposing clients to secondary infections such as Clostridioides difficile (watery diarrhea) and oral or vaginal candidiasis (thrush, yeast infections).
- Hypersensitivity & Anaphylaxis: Always screen clients for prior drug allergies (especially Penicillins and Cephalosporins, which exhibit cross-allergenicity). If anaphylaxis occurs, stop the infusion immediately, maintain airway, and administer epinephrine.
High-Risk Anti-Infectives
2. Vancomycin & Aminoglycosides Therapeutic Monitoring
Certain potent antibiotics require strict serum concentration monitoring to avoid irreversible organ toxicity while ensuring therapeutic efficacy.
Vancomycin (Glycopeptide)
Used for severe gram-positive infections including Methicillin-Resistant Staphylococcus aureus (MRSA) and C. diff (oral form).
- Trough Level Monitoring: Must be drawn exactly 30 minutes prior to administering the next scheduled IV dose. Ensures drug concentration remains within therapeutic range ($10\text{--}20\text{ mcg/mL}$).
- Red Man Syndrome: Infusion-related reaction caused by rapid IV infusion triggering massive histamine release. Features flushing of face, neck, and torso, pruritus, and hypotension. Action: Slow down the infusion rate.
- Nephrotoxicity & Ototoxicity: Monitor serum creatinine, BUN, and urine output. Assess for hearing loss or tinnitus.
Aminoglycosides (Gentamicin, Tobramycin)
Used for severe gram-negative bacterial infections.
- Nephrotoxicity: Accumulates in proximal renal tubules, causing acute tubular necrosis. Monitor baseline creatinine and BUN.
- Ototoxicity: Irreversible damage to cranial nerve VIII, resulting in tinnitus, dizziness, vertigo, and hearing loss.
- Peak and Trough Levels: Requires both peak levels (drawn 30 minutes after IV infusion completes) and trough levels (drawn right before next dose) to maintain therapeutic window and prevent toxicity.
Analgesic Pharmacology & Reversals
3. Opioid Analgesics, NSAIDs & Emergency Reversals
Pain management balances effective analgesia with patient safety, monitoring for respiratory depression, gastrointestinal ulceration, and organ toxicity.
1. Opioid Agonists (Morphine, Fentanyl, Hydromorphone, Oxycodone)
Binds to central nervous system mu-opioid receptors to alter pain perception. Adverse Effects: Respiratory depression (respiratory rate $< 12\text{ breaths/min}$), sedation, constipation (requires prophylactic stool softeners/laxatives), urinary retention, and nausea.
Emergency Reversal: Administer Naloxone (opioid antagonist) for respiratory depression. Note: Naloxone has a shorter half-life than most opioids; repeat doses may be required to prevent renarcotization.
2. Non-Opioids: NSAIDs (Ibuprofen, Ketorolac, Celecoxib) & Acetaminophen
NSAIDs: Inhibit cyclooxygenase (COX-1 and COX-2) enzymes, reducing prostaglandin synthesis. Adverse effects: GI ulceration/bleeding, renal impairment, and increased cardiovascular thrombotic events. Avoid in clients with renal failure or peptic ulcer disease.
Acetaminophen: Analgesic and antipyretic (does not reduce inflammation). Maximum daily dose: $4,000\text{ mg}$ ($4\text{ g}$). Chronic high doses cause severe hepatotoxicity. Antidote: Acetylcysteine (Mucomyst).
3. Key Reversal Agents Summary
• Naloxone: Reverses Opioids.
• Flumazenil: Reverses Benzodiazepines (e.g., Midazolam, Lorazepam).
• Protamine Sulfate: Reverses Unfractionated Heparin.
• Vitamin K (Phytonadione): Reverses Warfarin.
Glycemic Control Pharmacology
4. Insulin Kinetics Profiles & Administration Safety
Insulin therapy replaces endogenous insulin in Type 1 diabetes and manages persistent hyperglycemia in Type 2 diabetes. Nurses must master the onset, peak, and duration profiles of insulin classes to prevent hypoglycemic crises.
| Insulin Class & Prototypes |
Onste of Action |
Peak Effect |
Duration |
Clinical Nursing Rule |
| Rapid-Acting (Lispro, Aspart, Glulisine) |
10–15 minutes |
1 hour |
3–5 hours |
Must be administered within 0–15 minutes before a meal. Client must have food tray present. |
| Short-Acting (Regular Insulin) |
30–60 minutes |
2–4 hours |
5–8 hours |
The only insulin that can be administered via IV push or continuous infusion (used in DKA protocol). |
| Intermediate-Acting (NPH Insulin) |
1–2 hours |
4–12 hours |
18–24 hours |
Cloudy suspension. When mixing Regular and NPH, draw up Clear (Regular) before Cloudy (NPH) ("RN" rule). |
| Long-Acting (Glargine, Detemir) |
1–2 hours |
No peak (flat) |
24+ hours |
Provides steady basal coverage. Never mix long-acting insulins in the same syringe with any other insulin. |
Oral Antidiabetic Agents
5. Oral Hypoglycemics & Metformin Contrast Safety
Oral antidiabetic medications manage Type 2 Diabetes through various mechanisms targeting hepatic glucose production, insulin sensitivity, and pancreatic secretion.
Metformin (Biguanide)
First-line oral medication for Type 2 Diabetes. Reduces hepatic glucose production and enhances peripheral insulin sensitivity. Does not cause hypoglycemia when used alone.
Adverse Effects: GI upset (diarrhea, nausea), metallic taste, and rare lactic acidosis.
Crucial Contrast Rule: Metformin must be withheld 48 hours before and after any radiologic diagnostic test utilizing IV iodinated contrast media. Contrast dye impairs renal function, causing Metformin to accumulate and trigger fatal lactic acidosis. Serum creatinine must be verified normal prior to restarting.
NCLEX / ATI Board Style Question
Clinical Practice Drill
Domain: Pharmacology / Vancomycin Safety
Question: A nurse is preparing to administer an intermittent IV dose of Vancomycin to an adult client with a bone infection. Which of the following nursing actions is most important to ensure safe administration?
A) Administer the IV dose rapidly over 15 minutes to achieve peak concentration
Option A
B) Verify that a serum trough level was drawn 30 minutes prior to administration
Correct Answer ✓
C) Mix the Vancomycin solution with parenteral nutrition for simultaneous infusion
Option C
D) Monitor the client for hypoglycemia throughout the infusion
Option D
Clinical Rationale:
Correct Answer: B (Verify that a serum trough level was drawn 30 minutes prior to administration). Vancomycin has a narrow therapeutic index and carries risks of nephrotoxicity and ototoxicity. Verifying that a trough level has been drawn 30 minutes prior to the next dose ensures that serum concentrations are within the safe therapeutic window ($10\text{--}20\text{ mcg/mL}$).
Distractor Analysis: Rapid infusion over 15 minutes (Option A) causes Red Man Syndrome and severe hypotension; Vancomycin must be infused slowly over at least 60 minutes. Mixing with parenteral nutrition (Option C) risks incompatibility. Vancomycin does not cause hypoglycemia (Option D).
Frequently Asked Questions
High-Intent Pharmacology Queries
Why must Metformin be held before CT scans with IV contrast?
IV iodinated contrast media can cause temporary renal impairment. Because Metformin is excreted unchanged by the kidneys, impaired renal function causes Metformin to accumulate in the bloodstream, triggering fatal lactic acidosis. It must be held for 48 hours post-procedure until kidney function is confirmed normal.
What is the correct order for mixing Regular and NPH insulin?
Use the "RN" rule: Draw up Regular (Clear) before NPH (Cloudy). Inject air into NPH (cloudy), inject air into Regular (clear), withdraw Regular (clear), then withdraw NPH (cloudy). This prevents contaminating the clear regular insulin vial with cloudy intermediate insulin.
